Tag: AusCann
AusCann completes sale of its Chilean joint venture
Perth-based pharmaceutical company AusCann announced that it has finalised the sale of the company’s right, title and interest in its 50% owned Chilean joint...
AusCann’s Chilean JV to kick off crop cultivation with Khiron Life Sciences
Australian medicinal cannabis company AusCann has announced that its 50:50 Chilean joint venture, DayaCann, will commence its first third party cannabis cultivation activity with Canadian...
AusCann raises A$33.4m via share placement
ASX-listed medical marijuana company AusCann has successfully raised A$33.4 million via a share placement to institutional and sophisticated investors from North America and Australia, including...
AusCann moves to accelerate its Australian medical cannabis manufacturing operation
Leading cannabinoid pharmaceutical company AusCann Group has announced the appointment of Canadian Luke Pigeau as its new Master Grower, tasked with overseeing the company's...
Government moves to allow medical marijuana exports
The Federal Government has announced that Australian producers of medicinal cannabis will be allowed to export product to overseas market.
Making the announcement, Health Minister...
AusCann obtains manufacturing licence for medical cannabis
AusCann has been granted an Australian medicinal manufacturing licence by the Office of Drug Control that will enable the company to manufacture and supply...
Featured Article
The future of sports manufacturing: Inside M2M Group’s AI-powered strategy
As the sports manufacturing industry evolves, artificial intelligence (AI) is emerging as a critical catalyst for innovation and efficiency.
